Volume: 43 Issue: 1
Year: 2023, Page: 482-487, Doi: https://doi.org/10.51248/.v43i01.2686
Introduction and Aim: Beta-thalassemia is a hereditary blood disorder caused by genotypic alterations in the HBB gene. Over 400 mutations have been identified, which are known to be responsible for this disease. In this study, we investigated the mutations for the globin gene prevalent among adult beta-thalassemia trait positive individuals and their distribution within the Kodagu community of Karnataka, India.
Materials and Methods: This study included 100 individuals (81 Females and 19 males) in the age group of 18-28 years previously tested as carriers for beta-thalassemia trait. Blood collected from each individual was subjected to genomic DNA extraction and PCR amplification of a 610 bp fragment of the beta-globin gene. The PCR product was purified and sequenced. The gene sequences were subjected to mutation analyses and characterization using bioinformatics tools.
Results: The study identified 13 known and 27 novel mutations for this study population. Among the known mutations observed 2 were of type synonymous (HBB:c.9T>C and HBB:c.18T>G), 5 missense (HBB:c.146T>G; HBB:c.149C>T; HBB:c.151A>T; HBB:c.203T>G; HBB:c.269G >A) and 6 intronic (HBB:c.92+2T >G; HBB:c.92+5G>C; HBB:c.315+16G>C; HBB:c.315+74T>G and HBB:c.315+81C>T). HBB:c.-6G>C at the 5'UTR region and IVS-II-16 G>C, an intronic variant, was observed to be the most common mutation showing highest frequency of 82.1%. Several novel mutation types were identified in Exon 2 (3 missense; 2 synonymous), Intron I and Intron II.
Conclusion: This study is the first of its kind for the Kodagu population, which identified several previously known and novel mutations in the HBB gene within this population. Since, our study subjects were carriers of very mild or silent beta-thalassemia trait, the mutations observed particularly the novel mutations warrant further investigation for a better understanding and management of β-thalassemia in this population.
Keywords: Beta-thalassemia; beta -globin gene; HBB; Kodagu population; DNA sequencing.
1. Weatherall, D.J, Clegg, J.B. Inherited hemoglobin disorders: an increasing global health problem. Bull World Health Organ. 2001;79: 704-712.
2. Origa, R. beta-Thalassemia. Genet Med 2017;19: 609-619.
3. Cao, A, Galanello, R. beta-thalassemia. Genet Med. 2010;12: 61-76.
4. Thein, S.L. Molecular basis of beta-thalassemia and potential therapeutic targets. Blood Cells Mol Dis. 2018;70:54-65.
5. Colah, R, Gorakshakar, A., Nadkarni, A. Global burden, distribution and prevention of beta-thalassemia and hemoglobin E disorders. Expert Rev Hematol 2010;1:103-117.
6. Sahoo, S.S., Biswal, S., Dixit, M. Distinctive mutation spectrum of the HBB gene in an urban eastern Indian population. Hemoglobin. 2014; 38:33-38.
7. Shah, P.S., Shah, N.D., Ray, H.S.P., Khatri, N.B., Vaghasia, K.K., Raval, R.J., et al., Mutation analysis of beta-thalassemia in East-Western Indian population: a recent molecular approach. Appl Clin Genet. 2017;10:27-35.
8. Kirti, G., Minakshi, V., Pankaj, A., Shiksha, S., Ritu, Y. beta-thalassemia in India: current status and the challenges ahead. Int J Pharm Pharm Sci. 2014; l6: 28-33.
9. Vaz, F.E., Thakur, C.B., Banerjee, M.K., Gangal, S.G. Distribution of beta-thalassemia mutations in the Indian population referred to a diagnostic center. Hemoglobin. 2000;24: 181-194.
10. Suresh, B.T.V., Saritha, Ashwini, S., Manjula, S. Pre-nuptial status of heterozygous of beta-thalassemia in Kodagu population of Karnataka. Biomedicine. 2017; 37: 434-440.
11. Smigielski, E.M., Sirotkin, K., Ward, M., Sherry, S.T. dbSNP: a database of single nucleotide polymorphisms. Nucl. Acids Res. 2000;28: 352-355.
12. Hardison, R.C., Chui, D.H., Giardine, B., Riemer, C., Patrinos, G.P., Anagnou, N., et al., Hb Var: A relational database of human hemoglobin variants and thalassemia mutation at the globin gene server. Hum Mutat. 2002;19: 225-233.
13. Stephens, A.D., Angastiniotis, M., Baysal, E., Chan, V., Fucharoen, S., Giordano, P.C., et al., International Council for the Standardisation of Haematology (ICSH). ICSH recommendations for the measurement of haemoglobin A2. Int. J Lab Hematol. 2012;34:1-13.
14. Sharifi, A., Mahdieh, N. HBB mutations and HbA2 level: Escaping the carrier screening programs. Clin Case Rep. 2020;9: 973-977.
15. Panigrahi, I., Marwaha, R. Mutational spectrum of thalassemia in India. Ind J Hum Genet. 2007; 13:36-37.
16. Mishra, A.K., Tiwari, A. Screening and molecular characterization of beta-thalassaemia mutations in parents and siblings of beta-thalassaemia major patients. Ind J Basic Appl Medl Res. 2014;5: 481-486.
17. Olivieri, N.F. The beta-thalassemias. N Engl J Med. 1999;341: 99-109.
18. Treisman, R., Orkin, S.H., Maniatis, T. Specific transcription and RNA splicing defects in five cloned beta-thalassemia genes. Nature. 1983; 301:591-596.
19. Charache, S., Brimhall, B., Milner, P. Hemoglobin Okaloosa (beta 48 (CD7) leucine leads to arginine). An unstable variant with low oxygen affinity. J Clin Invest. 1973; 52: 2858-2864
20. Malcorra-Azpiazu, J.J., Balda-Aguirre, M.I., Diaz-Chico, J.C., Hu, H., Wilson, J.B., Webber, B.B., et al., Hb Las Palmas or alpha 2 beta 2(49)(CD8) Ser--Phe, a mildly unstable hemoglobin variant. Hemoglobin. 1988;12:163-170.
21. Fay, K.C., Brennan, S.O., Costello, J.M., Potter, H.C., Williamson, D.A., Trent, R.J., et al., Haemoglobin Manukau beta 67[E11] Val-->Gly: transfusion-dependent haemolytic anaemia ameliorated by coexisting alpha thalassaemia. Br J Haematol. 1993;85: 352-355.
22. Carrell, R.W., Lehmann, H., Lorkin, P.A., Raik, E., Hunter, E. Haemoglobin Sydney: beta-67 (E11) valine modified to alanine: an emerging pattern of unstable haemoglobins. Nature. 1967; 215(5101):626-628.
23. Udem, L., Ranney, H.M., Bunn, H.F., Pisciotta, A. Some observations on the properties of hemoglobin M Milwaukee-1. J Mol Biol. 1970; 48:489-498.
24. Arnone, A., Thillet, J., Rosa, J. The structure of hemoglobin Creteil (beta 89 Ser replaced by Asn) is similar to that of abnormal human hemoglobins having sequence changes at Tyr 145 β. J Biol Chem. 1981;256:8545-8552.
25. Gururaj, D.K., Suyamindra, S.K., Gurushantappa, S.K., Bhushan, B. K., Prakashgouda, H.K., Bhaskar, V.K.S.L., et al., Molecular basis of beta-Thalassemia in Karnataka, India. Genetic Testing and Molecular Biomarkers. 2012;16: 138-141.
26. Kazazian, H.H. Jr, Orkin, S.H., Antonarakis, S.E., Sexton, J.P., Boehm, C.D., Goff, S.C., et al., Molecular characterization of seven beta-thalassemia mutations in Asian Indians. EMBO J. 1984; 3:593-596.
27. Warsy, A.S, El Hazmi, M.A., Al Momin, A.K., Al Hazmi, A., Aleem A. Extensive polymorphisms in Saudi beta thalassaemia patients. Biosci Biotechnol Res Asia. 2013;10: 127-132
Suresh Babu T. V., Shama Prasada Kabekkodu., K. Satyamoorthy, Manjula Shantaram. Molecular characterization and mutational analysis of beta-globin gene among Kodagu population of Karnataka, India. Biomedicine: 2023; 43(1): 482-487